pCDCAR1 HER2 h(4γ), T(CAR-T-2-M550-4G)
The vector of anti-HER2 chimeric antigen receptor(CAR) is constructed for the engineering of T cell to target human HER2. The T cell is genetically modified through transduction with a lentiviral vector expressing anti-HER2 VHH linked to CD4 transmembrane domain and FcεRIγ signaling domains. And the vector product was designed for the treatment of breast cancer, hepatocellular liver carcinoma.
Targeting Cell Type
Breast cancer; hepatocellular liver carcinoma
Discription of Signaling Cassetes
Cluster of Differentiation 4 (CD4) is a glycoprotein expressed on the surface of T helper cells, regulatory T cells, monocytes, macrophages and dendritic cells, and plays an important role in the development and activation of T cells. On T cells, CD4 is the co-receptor for the T cell receptor (TCR), and these two distinct structures recognize the Antigen-Major Histocompatibility Complex (MHC). CD4 signaling in CAR ensures specificity of the TCR-antigen interaction, prolongs the contact between the T cell and the antigen presenting cell and recruits the tyrosine kinase Lck, which is essential for T cell activation.
The high-affinity IgE receptor, also known as FcεRI, or Fc epsilon RI, is the high-affinity receptor for the Fc region of immunoglobulin E (IgE). FcεRI is a key molecule involved in allergic reactions. It is a tetramer composed of 1alpha, 1 beta, and 2 gamma chains. The gamma chains are also subunits of other Fc receptors. The scFv-based CARs engineered to contain a signaling domain from FcεRIγ have been shown to deliver a potent signal for T cell activation and function.
erb-b2 receptor tyrosine kinase 2
ERBB2; erb-b2 receptor tyrosine kinase 2; NEU; NGL; HER2; TKR1; CD340; HER-2; MLN 19; HER-2/neu; receptor tyrosine-protein kinase erbB-2; herstatin; p185erbB2; proto-oncogene Neu; c-erb B2/neu protein; proto-oncogene c-ErbB-2; metastatic lymph node gene 19 protein; human epidermal growth factor receptor 2; neuro/glioblastoma derived oncogene homolog; tyrosine kinase-type cell surface receptor HER2; neuroblastoma/glioblastoma derived oncogene homolog; v-erb-b2 avian erythroblastic leukemia viral oncoprotein 2; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2; v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog; CD28; Chimeric antigen receptor; T cell; Retrovirus; CARs; Lentivirus; chimeric T cell receptors; chimeric immunoreceptors; chimeric antigen receptors; scFv; OTI5C4
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
||Anti-ErbB2 (L96) h(CD28-FcγR) CAR, pCDCAR1
||Anti-HER2 VHH h(CD8-CD3ζ) CAR, [T]
||Lenti-ErbB2 CAR (scFv-CD28-FcγR, 4D5 ) Viral Particle
||Murinized anti-HER2 T cell receptor (HER2-1 ), pCDTCR1
||Anti-ErbB2 scFv h(CD4-CD3ζ) CARNK, pCDCAR1
||Anti-ErbB2 scFv h(FcεRIγ) CARNK, pCDCAR1
||Lenti-ErbB2 CAR (scFv-CD28-CD3ζ, C6-B1D2) Viral Particle
||Lenti-Her2 T cell receptor (E2) Viral Particle
||Anti-ErbB2 (4D5 ) h(CD28-FcγR) CAR, pCDCAR1
||Lenti-ErbB2 CAR (scFv-CD8-CD3ζ, OTI5C4) Viral Particle
||Lenti-ErbB2 CAR (scFv-CD28-CD3ζ, Trastuzumab) Viral Particle
||Lenti-Her2 T cell receptor (B7) Viral Particle
||Anti-HER2 VHH h(CD3ζ) CAR, [T]
||Anti-ErbB2 (C6MH3-B1) h(CD28-CD3ζ) CAR, pCDCAR1
||Lenti-ErbB2 CAR (scFv-CD28-41BB-CD3ζ, OTI5C4) Viral Particle
||Lenti-HER2 T cell receptor (HER2-1) Viral Particle
||Lenti-ErbB2 CAR (scFv-CD28-CD3ζ, C6.5G98A) Viral Particle
||Lenti-ErbB2 CAR (scFv-CD28-CD3ζ, C6.5) Viral Particle
||Murinized anti-HER2 T cell receptor (HER2-3), pCDTCR1
||Anti-ErbB2 scFv h(b2c-CD3ζ) CART, pCDCAR1